Aug 26, 2021 04:05PM
Aug 26, 2021 04:05PM
Aug 24, 2021 12:58PM
Aug 24, 2021 12:58PM
Aug 19, 2021 07:30AM
Aug 17, 2021 07:30AM
Aug 17, 2021 07:30AM Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs
Aug 13, 2021 07:30AM
Aug 11, 2021 07:30AM
Aug 11, 2021 07:30AM
Aug 4, 2021 04:52PM
Aug 4, 2021 04:52PM
Jul 22, 2021 07:30AM
Jul 22, 2021 07:30AM Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop
Jun 11, 2021 03:03PM
Jun 11, 2021 03:03PM
Jun 11, 2021 07:30AM
Jun 11, 2021 07:30AM
Jun 10, 2021 07:30AM
Jun 8, 2021 07:30AM
Jun 8, 2021 07:30AM Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment
Jun 4, 2021 07:30AM
Jun 4, 2021 07:30AM
May 26, 2021 07:30AM
May 22, 2021 03:50PM
May 21, 2021 07:30AM
May 21, 2021 07:30AM
May 19, 2021 04:30PM Humacyte Appoints Dale Sander as Chief Financial Officer
May 19, 2021 04:30PM
May 6, 2021 07:30AM
Apr 21, 2021 08:00AM
Apr 21, 2021 08:00AM
Apr 14, 2021 07:30AM
Apr 14, 2021 07:30AM
Mar 23, 2021 07:30AM Humacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online Summit
Mar 11, 2021 07:30AM
Mar 11, 2021 07:30AM
Mar 5, 2021 07:31AM
Mar 5, 2021 07:30AM
Mar 5, 2021 07:30AM
Feb 17, 2021 07:02AM
Feb 17, 2021 07:00AM Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthca
Feb 17, 2021 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All